4.7 Review

Mesenchymal stem cells: A revolution in therapeutic strategies of age-related diseases

Journal

AGEING RESEARCH REVIEWS
Volume 12, Issue 1, Pages 103-115

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.arr.2012.04.005

Keywords

MSCs; Age-related diseases; Aging; Myocardial infarction; Neurodegenerative diseases; Type II diabetes

Funding

  1. National Basic Science and Development Program (973 Program) [2012CB518105]
  2. National Natural Science Foundation of China [81121004, 81171812, 30871028, 81000843]

Ask authors/readers for more resources

The great evolutionary biologist Theodosius Dobzhansky once said: Nothing in biology makes sense except in the light of evolution. Aging is a complex biological phenomenon and the factors governing the process of aging and age-related diseases are only beginning to be understood, oxidative stress, telomere shortening in DNA components and genetic changes were shown to be the mainly regulating mechanisms during the recent decades. Although a considerable amount of both animal and clinical data that demonstrate the extensive and safe use of mesenchymal stromal cells (MSCs) is available, the precise summarization and identification of MSCs in age-related diseases remains a challenge. Along this line, this review discussed several typical age-related diseases for which MSCs have been proved to confer protection and put forward a hypothesis for the association among MSCs and age-related diseases from an evolutionary perspective. Above all, we hope further and more research efforts could be aroused to elucidate the role and mechanisms that MSCs involved in the age-related diseases. (c) 2012 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available